Session » Abstracts: RA – Diagnosis, Manifestations, and Outcomes III: RA ILD
- 4:30PM-6:00PM
-
Abstract Number: 2250
Genetic and Environmental Risk Factors in Rheumatoid Arthritis-Associated Interstitial Lung Disease
- 4:30PM-6:00PM
-
Abstract Number: 2252
Higher Matrix Metalloproteinase Levels Are Predictive of Incident Interstitial Lung Disease Among a Cohort of US Veterans with Rheumatoid Arthritis
- 4:30PM-6:00PM
-
Abstract Number: 2249
Impact of Interstitial Lung Disease on COVID-19 Severity Among Patients with Rheumatoid Arthritis: A Multicenter Comparative Study
- 4:30PM-6:00PM
-
Abstract Number: 2248
Prevalence and Mortality of Interstitial Lung Abnormalities in Rheumatoid Arthritis and non-RA Comparators in a Multicenter Prospective Cohort
- 4:30PM-6:00PM
-
Abstract Number: 2251
Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in Patients Treated with Tofacitinib
- 4:30PM-6:00PM
-
Abstract Number: 2253
Sputum Cytokines Are Elevated in Rheumatoid Arthritis-Associated Interstitial Lung Disease